Treatment with low dose metformin in patients with peripheral vascular disease.

[1]  L. Hillestad.  The peripheral blood flow in intermittent claudication. IV. The significance of the claudication distance. , 2009, Acta medica Scandinavica.

[2]  S. G. Rains,et al.  The Reduction of Low Density Lipoprotein Cholesterol by Metformin is Maintained with Long-Term Therapy , 1989, Journal of the Royal Society of Medicine.

[3]  P. Waller,et al.  Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985. , 1988, British journal of clinical pharmacology.

[4]  V. Bertele',et al.  Defective Fibrinolytic Response in Atherosclerotic Patients – Effect of lloprost and Its Possible Mechanism of Action , 1988, Thrombosis and Haemostasis.

[5]  M. Alessi,et al.  Metformin Decreases the High Plasminogen Activator Inhibition Capacity, Plasma Insulin and Triglyceride Levels in Non-Diabetic Obese Subjects , 1987, Thrombosis and Haemostasis.

[6]  C. Cerletti,et al.  Low dose aspirin does not prevent fibrinolytic response to venous occlusion. , 1986, Biochemical pharmacology.

[7]  N. Rifai,et al.  Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum. , 1986, Clinical chemistry.

[8]  R. Thompson,et al.  Circulating antibodies to mouse monoclonal immunoglobulins in normal subjects--incidence, species specificity, and effects on a two-site assay for creatine kinase-MB isoenzyme. , 1986, Clinical chemistry.

[9]  K. Balzer,et al.  Buflomedil in Arterial Occlusive Disease: Results of a Controlled Multicenter Study , 1984, Angiology.

[10]  K. Salmenkivi,et al.  Effects of Flunarizine and Pentoxifylline on Walking Distance and Blood Rheology in Claudication , 1984, Angiology.

[11]  D. Strandness,et al.  Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. , 1982, American heart journal.

[12]  Uno Erikson,et al.  REGRESSION OF COMPUTER ESTIMATED FEMORAL ATHEROSCLEROSIS AFTER PRONOUNCED SERUM LIPID LOWERING IN PATIENTS WITH ASYMPTOMATIC HYPERLIPIDAEMIA , 1982, The Lancet.

[13]  J. Albers,et al.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.

[14]  G. Franceschini,et al.  Increased Apoprotein B in Very Low Density Lipoproteins of Patients with Peripheral Vascular Disease , 1982, Arteriosclerosis.

[15]  H. Rüdiger,et al.  Biguanide treatment increases the number of insulin-receptor sites on human erythrocytes. , 1981, The New England journal of medicine.

[16]  C. Clyne.  Non-surgical management of peripheral vascular disease: a review. , 1980, British medical journal.

[17]  M. Sanmarco,et al.  Spatial reconstruction of human femoral atheromas showing regression. , 1979, The American journal of medicine.

[18]  L. Smith,et al.  Quantitative coronary arteriography. Coronary anatomy of patients with unstable angina pectoris reexamined 1 year after optimal medical therapy. , 1979, The American journal of cardiology.

[19]  G. Franceschini,et al.  Disposition of metformin (N,N‐dimethylbiguanide) in man , 1978, Clinical pharmacology and therapeutics.

[20]  A. Jageneau,et al.  Modern Techniques of Venous Occlusion Plethysmography in the Assessment of Peripheral Vascular Disease , 1977, Proceedings of the Royal Society of Medicine.

[21]  C. Sirtori,et al.  Treatment of hypertriglyceridemia with metformin. Effectiveness and analỳsis of results. , 1977, Atherosclerosis.

[22]  D. Blankenhorn,et al.  Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients. , 1977, Annals of internal medicine.

[23]  C. Sirtori,et al.  Diet, lipids and lipoproteins in patients with peripheral vascular disease , 1974, The American journal of the medical sciences.

[24]  G Bucolo,et al.  Quantitative determination of serum triglycerides by the use of enzymes. , 1973, Clinical chemistry.

[25]  C. Sirtori,et al.  Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits. , 1982, Atherosclerosis.

[26]  C. Sirtori,et al.  Long-term treatment with metformin in a large cohort of hyperlipidemic patients , 1978 .

[27]  C. Sirtori,et al.  Metaformin: an antiatherosclerotic agent modifying very low density lipoproteins in rabbits. , 1977, Atherosclerosis.

[28]  C. Sirtori,et al.  Turnover and aortic uptake of very low density lipoproteins (VLDL) from hypercholesteremic rabbits as a model for testing antiatherosclerotic compounds. , 1976, Advances in experimental medicine and biology.

[29]  P. Röschlau,et al.  Enzymatische Bestimmung des Gesamt-Cholesterins im Serum , 1974 .

[30]  Petersen Fb.  The effects of varying walking speeds when measuring the claudication distance on horizontal and sloping levels. , 1967 .

[31]  O. Thulesius.  The significance of vasodilator therapy in obliterative arterial disease. , 1967, Scandinavian journal of clinical and laboratory investigation. Supplementum.